全文获取类型
收费全文 | 159035篇 |
免费 | 50030篇 |
国内免费 | 3555篇 |
专业分类
耳鼻咽喉 | 2382篇 |
儿科学 | 5929篇 |
妇产科学 | 2982篇 |
基础医学 | 25098篇 |
口腔科学 | 6410篇 |
临床医学 | 22589篇 |
内科学 | 36554篇 |
皮肤病学 | 8800篇 |
神经病学 | 17732篇 |
特种医学 | 5449篇 |
外国民族医学 | 13篇 |
外科学 | 23038篇 |
综合类 | 10167篇 |
现状与发展 | 13篇 |
一般理论 | 36篇 |
预防医学 | 10079篇 |
眼科学 | 3221篇 |
药学 | 13778篇 |
60篇 | |
中国医学 | 4444篇 |
肿瘤学 | 13846篇 |
出版年
2024年 | 135篇 |
2023年 | 817篇 |
2022年 | 1884篇 |
2021年 | 4429篇 |
2020年 | 7075篇 |
2019年 | 12631篇 |
2018年 | 12412篇 |
2017年 | 13294篇 |
2016年 | 13877篇 |
2015年 | 14850篇 |
2014年 | 15743篇 |
2013年 | 16608篇 |
2012年 | 10912篇 |
2011年 | 10882篇 |
2010年 | 13272篇 |
2009年 | 9159篇 |
2008年 | 7114篇 |
2007年 | 6061篇 |
2006年 | 5851篇 |
2005年 | 5084篇 |
2004年 | 4483篇 |
2003年 | 4360篇 |
2002年 | 3866篇 |
2001年 | 3304篇 |
2000年 | 2825篇 |
1999年 | 2002篇 |
1998年 | 815篇 |
1997年 | 704篇 |
1996年 | 587篇 |
1995年 | 512篇 |
1994年 | 479篇 |
1993年 | 308篇 |
1992年 | 797篇 |
1991年 | 631篇 |
1990年 | 569篇 |
1989年 | 530篇 |
1988年 | 447篇 |
1987年 | 450篇 |
1986年 | 376篇 |
1985年 | 317篇 |
1984年 | 241篇 |
1983年 | 198篇 |
1982年 | 122篇 |
1981年 | 138篇 |
1980年 | 106篇 |
1979年 | 213篇 |
1978年 | 167篇 |
1977年 | 105篇 |
1976年 | 113篇 |
1975年 | 110篇 |
排序方式: 共有10000条查询结果,搜索用时 375 毫秒
991.
Erez T. Yirmiya Ehud Mekori‐Domachevsky Ronnie Weinberger Michal Taler Miri Carmel Doron Gothelf 《American journal of medical genetics. Part A》2020,182(3):461-468
22q11.2 deletion syndrome (22q11.DS) is a neurogenetic disorder caused by a microdeletion in chromosome 22. Its phenotype includes high rates of psychiatric disorders, immune system abnormalities, and cognitive impairments. We assessed the quality of sleep in 22q11.2DS and its potential link to inflammatory markers and cognitive deficits. Thirty‐three 22q11.2DS individuals and 24 healthy controls were studied. Sleep parameters were assessed by the Pittsburgh sleep quality index (PSQI) questionnaire and correlated with serum cytokine levels and cognitive functioning, measured using the Penn computerized neurocognitive battery (CNB). The 22q11.2DS individuals had significantly worse sleep quality scores than the controls, unrelated to the psychiatric or physical comorbidities common to 22q11.2DS. Interleukin 6 levels were correlated with the overall score of the PSQI questionnaire for nonpsychotic 22q11.2DS participants only. Several domains of the CNB were associated with poorer sleep quality, suggesting that cognitive impairments in 22q11.2DS may be at least partially explained by poor sleep quality. Our findings confirm sleep impairments in individuals with 22q11.2DS, which might negatively affect their cognitive functioning, and corroborate a potential role of immunological pathways in the 22q11.2DS neuro‐phenotype. 相似文献
992.
Alexandra P. Key Hatun Zengin‐Bolatkale Anastasia Dimitropoulos Ellen Doernberg 《American journal of medical genetics. Part A》2020,182(7):1655-1663
This study examined sensitivity of eye tracking measures to hyperphagia severity in Prader‐Willi syndrome (PWS). Gaze data were collected in 57 children with PWS, age 3–11 years, and 47 typically developing peers at two study sites during free visual exploration of complex stimulus arrays that included images of food, animals, and household objects. Analysis of the number and duration of fixations as well as gaze perseverations revealed that food items are not exceptionally salient for children with PWS. Instead, increased attention to food in the context of other high‐interest items (e.g., animals) was associated with caregiver reports of more severe hyperphagia and more advanced nutritional phase. The study also provided preliminary evidence of possible genetic subtype and sex differences as well as demonstrated that multiple investigators in a wide range of settings can effectively implement the eye tracking protocol. The results indicate that gaze characteristics derived from eye tracking may be a promising objective marker of hyperphagia in PWS for use in research and clinical trials. 相似文献
993.
Mersedeh Rohanizadegan Sarah Tracy Carolina I. Galarreta Tabitha Poorvu Terry L. Buchmiller Lynne M. Bird Judy A. Estroff Wen‐Hann Tan 《American journal of medical genetics. Part A》2020,182(8):1890-1895
Esophageal atresia (EA) is a congenital anomaly occurring in 2.3 per 10,000 live births. Due to advances in prenatal imaging, EA is more readily diagnosed, but data on the associated genetic diagnoses, other anomalies, and postnatal outcome for fetuses diagnosed prenatally with EA are scarce. We collected data from two academic medical centers (n = 61). Our data included fetuses with suspected EA on prenatal imaging that was confirmed postnatally and had at least one genetic test. In our cohort of 61 cases, 29 (49%) were born prematurely and 19% of those born alive died in the first 9 years of life. The most commonly associated birth defects were cardiac anomalies (67%) and spine anomalies (50%). A diagnosis was made in 61% of the cases; the most common diagnoses were vertebral defects, anal atresia, cardiac anomalies, tracheoesophageal fistula with esophageal atresia, radial or renal dysplasia, and limb anomalies association (43%, although 12% met only 2 of the criteria), trisomy 21 (5%), and CHARGE syndrome (5%). Our findings suggest that most fetuses with prenatally diagnosed EA have one or more additional major anomaly that warrants a more comprehensive clinical genetics evaluation. Fetuses diagnosed prenatally appear to represent a cohort with a worse outcome. 相似文献
994.
Tim Phetthong Thipwimol Tim‐Aroon Arthaporn Khongkrapan Preamrudee Poomthavorn Duangrurdee Wattanasirichaigoon 《American journal of medical genetics. Part A》2020,182(8):1873-1876
Kabuki syndrome (KS) is a rare heterogeneous phenotypic genetic syndrome, characterized by hypotonia, developmental delay and/or intellectual disability with typical facial features. It is challenging to diagnose KS in newborn and young infant. We report a Thai girl who presented with two rare co‐occurrence phenotypes, hyperinsulinemic hypoglycemia and midgut malrotation. She had not have distinctive facial dysmorphism during neonatal period. At 4 months of age, she had poor weight gain with some facial features suggestive KS. Singleton whole exome sequencing (WES) was carried out followed by Sanger sequencing of the supposed variant. The result indicated a novel de novo heterozygous KMT2D mutation, c.15364A>T (p.Lys5122*), confirming KS. Our patient revealed rare clinical manifestations from the diverse population and address the benefit of WES in establishing early diagnosis of KS before typical facial gestalt exhibited, which allows timely and appropriate management to maximize developmental achievement. 相似文献
995.
Xiao Liu Xiaohong Meng Lizhu Yang Yanling Long Yu Fujinami‐Yokokawa Jiayun Ren Toshihide Kurihara Kazuo Tsubota Kazushige Tsunoda Kaoru Fujinami Shiying Li East Asia Inherited Retinal Disease Society Study Group 《American journal of medical genetics. Part C, Seminars in medical genetics》2020,184(3):694-707
Stargardt disease 1 (STGD1) is the most prevalent retinal dystrophy caused by pathogenic biallelic ABCA4 variants. Forty‐two unrelated patients mostly originating from Western China were recruited. Comprehensive ophthalmological examinations, including visual acuity measurements (subjective function), fundus autofluorescence (retinal imaging), and full‐field electroretinography (objective function), were performed. Next‐generation sequencing (target/whole exome) and direct sequencing were conducted. Genotype grouping was performed based on the presence of deleterious variants. The median age of onset/age was 10.0 (5–52)/29.5 (12–72) years, and the median visual acuity in the right/left eye was 1.30 (0.15–2.28)/1.30 (0.15–2.28) in the logarithm of the minimum angle of resolution unit. Ten patients (10/38, 27.0%) showed confined macular dysfunction, and 27 (27/37, 73.7%) had generalized retinal dysfunction. Fifty‐eight pathogenic/likely pathogenic ABCA4 variants, including 14 novel variants, were identified. Eight patients (8/35, 22.8%) harbored multiple deleterious variants, and 17 (17/35, 48.6%) had a single deleterious variant. Significant associations were revealed between subjective functional, retinal imaging, and objective functional groups, identifying a significant genotype–phenotype association. This study illustrates a large phenotypic/genotypic spectrum in a large well‐characterized STGD1 cohort. A distinct genetic background of the Chinese population from the Caucasian population was identified; meanwhile, a genotype–phenotype association was similarly represented. 相似文献
996.
997.
Shyh Ren Chiang Hung Jen Tang Ping Chin Chang Kuo Chen Cheng Wen Chien Ko Chung Hua Chen Yin Ching Chuang 《Journal of microbiology, immunology, and infection》2007,40(2):123-133
BACKGROUND AND PURPOSE: Vibrio vulnificus causes primary bacteremia and necrotizing wound infection, leading to high morbidity and mortality in humans. This study aimed to evaluate the antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of V. vulnificus infection. METHODS: We investigated the dynamics of proinflammatory cytokines and their modulation by antimicrobial agents using a murine model of V. vulnificus infection. The change in cytokine levels was followed over a time course to identify the antimicrobial activity of the drugs against V. vulnificus. BALB/c female mice were challenged with an intraperitoneal infection using a clinical invasive isolate of Vv05191, and their cytokine levels were assayed over various time points. RESULTS: Serum levels of tumor necrosis factor-alpha, interleukin (IL)-1 beta, and IL-6 post-infection were found to be inoculum dose-dependent and positively correlated to the subsequent fatality rate in the infected mice. With an inoculum of 6.6 x 10(6) colony-forming units and intraperitoneal administration of cefotaxime, minocycline, or both, the serum and peritoneal fluid cytokine levels increased and then declined gradually. Comparison of the 3 antimicrobial regimens revealed that the magnitude of reduction in cytokine levels was greatest in mice treated with cefotaxime-minocycline combination. Moreover, the peritoneal fluid cytokine level in the combination group was significantly lower than that in the groups treated with minocycline or cefotaxime alone. CONCLUSIONS: The current results support the superiority of the combination therapy in treating invasive V. vulnificus infections. 相似文献
998.
具有三层管壁结构组织工程血管支架的生物力学性能 总被引:2,自引:0,他引:2
目的针对组织工程血管的体内培养技术路线,对所制备的具有三层管壁结构的组织工程血管支架的生物力学性能进行测试,并研究了壁厚对支架力学性能的影响,以保证后续的动物体内移植实验能顺利进行。方法采用涂敷,喷涂.滤沥的方法制备了具有三层管壁结构(多孔PLGA层.致密PU层.多孔PLGA层)的可降解组织工程血管支架,用自制的设备测试了其爆破强度和径向顺应性,并对血管支架进行了缝合强度的测试。结果所制备的厚度为0.295mm-0.432mm的三层结构血管支架的径向顺应性为3.80%/100mmHg-0.57%/100mmHg,爆破强度为160kPa~183kPa,缝合强度为0.63N/针~1.52N/针。结论支架的管壁厚度,尤其是中间层厚度,对支架的力学性能有重要影响。增大壁厚可导致径向顺应性急剧下降,爆破强度和缝合强度线性提高。在所制备的样品中,管壁厚度为0.295mm的支架其综合力学性能最优,可满足血管组织工程体内植入的力学性能要求。 相似文献
999.
Qi X Kondoh K Yin H Wang M Ponce E Sun Y Grabowski GA 《Molecular genetics and metabolism》2002,76(3):189-200
Saposin C is a biological activator of acid beta-glucosidase (GCase), the lysosomal hydrolase with activity towards glucosylceramide (GC). In addition, saposin C possesses a functional domain that determines the in vitro and ex vivo neuritogenic effects of prosaposin, the precursor of saposins A, B, C, and D. The domains for enzymatic activation and neuritogenic function segregate in vitro, respectively, to the carboxyl- and amino-terminal halves of human and mouse saposin C. A chimeric mouse saposin C(1-8)B(8-28)C(30-80) was created to obliterate the neuritogenic region by substituting amino acids 9-29 of saposin C with amino acids 8-28 of saposin B. This saposin showed normal in vitro enzymatic activation effects toward GCase, but no neuritogenic activity. An altered prosaposin was made to contain the chimeric saposin C region. Expression of this altered or wild-type prosaposin was driven by the PGK-1 promoter as a transgene in prosaposin knock-out mice. In cultured fibroblasts from such mice, expressed saposins localized to the lysosomal compartments. Metabolic lipid labeling using L-[3-(14)C]serine showed retention or clearance of GC in prosaposin deficient or transgene reconstituted cells, respectively. In addition, sulfatide catabolism, that requires saposin B and arylsulfatase, was also normalized in prosaposin KO cells reconstituted with the transgenes. These data show that the transgenic prosaposins were expressed and processed to functional saposins in fibroblasts. These results also show that the enzymatic activation domain is located at carboxyl-terminal half of saposin C and functions only in the context of the general saposin structure. 相似文献
1000.
Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs 总被引:6,自引:0,他引:6
Many peptides and transmitters found within the brain also have peripheral sites of action. We now demonstrate that the brain releases functionally active neurotransmitters/neuromodulators directly from the brain into the blood through a saturable P-glycoprotein (Pgp) transport system. Downregulating Pgp1 expression with antisense reduced the brain-to-blood transport of morphine, beta-endorphin and other opioids. Lowering Pgp expression significantly enhanced systemic morphine analgesia and prevented tolerance, but diminished the analgesic activity of centrally administered morphine, implying that supraspinal analgesia resulted from a combination of central and peripheral mechanisms activated by morphine transported from the brain to the blood. Similarly, mice with a disruption of the Mdr1a gene were more sensitive to systemic morphine and less sensitive to morphine given centrally. This ability of the Pgp transport system to pump functionally active compounds from the brain to periphery defines a potentially important mechanism for the central nervous system to modulate peripheral systems. 相似文献